Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity

Area of Science:

• Biochemistry
• Cardiology
• Molecular Biology

Background:

• Doxorubicin (DOX) is a vital chemotherapy drug, but its use is limited by cardiotoxicity.
• DOX-induced cardiotoxicity involves mitochondrial dysfunction, reactive oxygen species (ROS) generation, and cardiomyocyte death.
• Mitochondrial sirtuins (SIRT3-SIRT4) are crucial regulators of mitochondrial function and cellular stress responses.

Purpose of the Study:

• To review the role of mitochondrial sirtuins in mitochondrial biology.
• To elucidate the involvement of mitochondrial sirtuins in Doxorubicin-induced cardiotoxicity.
• To highlight unexplored roles of mitochondrial sirtuins in mitophagy and mitochondrial quality control.

Main Methods:

• Literature review focusing on mitochondrial sirtuins and Doxorubicin cardiotoxicity.
• Analysis of cellular mechanisms linking sirtuins to mitochondrial function.
• Identification of pathways regulated by sirtuins, including antioxidant defense, apoptosis, and autophagy.

Main Results:

• Mitochondrial sirtuins are central to preserving mitochondrial function under DOX stress.
• Sirtuins activate manganese-dependent superoxide dismutase (MnSOD) to inhibit ROS generation.
• Sirtuins modulate apoptosis via FOXO and P53 pathways and autophagy via AMPK/mTOR signaling.

Conclusions:

• Mitochondrial sirtuins are critical regulators of cellular processes affected by DOX-induced cardiotoxicity.
• Targeting mitochondrial sirtuins may offer a therapeutic strategy to mitigate DOX cardiotoxicity.
• Further research is needed to explore sirtuin roles in mitophagy and mitochondrial quality control in cardiotoxicity.